Cargando…
Characterization of cancer omics and drug perturbations in panels of lung cancer cells
To better understand the disruptions of transcriptional regulations and gene expression in lung cancers, we constructed a multi-omics catalogue of the responses of lung cancer cells to a series of chemical compounds. We generated and analyzed 3,240 RNA-seq and 3,393 ATAC-seq libraries obtained from...
Autores principales: | Suzuki, Ayako, Onodera, Keiichi, Matsui, Ken, Seki, Masahide, Esumi, Hiroyasu, Soga, Tomoyoshi, Sugano, Sumio, Kohno, Takashi, Suzuki, Yutaka, Tsuchihara, Katsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925249/ https://www.ncbi.nlm.nih.gov/pubmed/31863083 http://dx.doi.org/10.1038/s41598-019-55692-9 |
Ejemplares similares
-
Identification of potential regulatory mutations using multi-omics analysis and haplotyping of lung adenocarcinoma cell lines
por: Sereewattanawoot, Sarun, et al.
Publicado: (2018) -
Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines
por: Suzuki, Ayako, et al.
Publicado: (2014) -
Identification and Characterization of Cancer Mutations in Japanese Lung Adenocarcinoma without Sequencing of Normal Tissue Counterparts
por: Suzuki, Ayako, et al.
Publicado: (2013) -
Sequencing and phasing cancer mutations in lung cancers using a long-read portable sequencer
por: Suzuki, Ayako, et al.
Publicado: (2017) -
Evaluation and application of RNA-Seq by MinION
por: Seki, Masahide, et al.
Publicado: (2019)